Integra LifeSciences Recalls MEDIHONEY Calcium Alginate Dressings Due to Potential Sterility Breach
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Integra LifeSciences Corp. is recalling over 55,000 units of MEDIHONEY Calcium Alginate dressings because packaging failures may have compromised the sterile barrier of the products.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on March 3, 2026 and geographically references Worldwide. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Integra LifeSciences Corp. (NeuroSciences) has initiated a voluntary recall of MEDIHONEY Calcium Alginate dressings. The recall was prompted by potential packaging failures that could lead to a breach in the product's sterile barrier. This issue was identified as a Class II recall by the FDA.
Which Products Are Affected
The recall affects 55,276 units of MEDIHONEY CALCIUM ALGINATE WITH ACTIVE LEPTOSPERMUM HONEY. These dressings are indicated for the management of moderately to heavily exuding wounds. The following models and lot numbers are included:
- Model Number 31012 (UDI-DI: 10381780486909): Lots A24008, A24057, B21123, B24075, C22159, C23177, C24148, D24190, E21365, E24254, E24255, G23393, H21523, H22452, H23443, I22512, I23464, J21693, L22706.
- Model Number 31022 (UDI-DI: 10381780486916): Lots A23045, A23065, A25028, A25056, B23079, B25068, B25077, C21151, C21152, C21155, C21195, C22182, C22196, C23183, C23193, C25152, D23196, D23208, E21300, E22305, E22319, F21407, F21428, F21430, F22333, F24317, G23405, H21544, H22438, H23415, H23442, H23446, H24415, I21610, I21617, J22530, J23551, J23560, J24622, K21723, K21739, K24625, K24646, L21838.
- Model Number 31045 (UDI-DI: 10381780486923): Lots A21056, A22036, A22047, A24036, B21062, B21084, B21100, B21107, B21119, B25110, D21229, D21247, D22251, D22270, D22275, D23236, D23248, D24192, D24220, E21314, E21337, E21361, E22277, E23253, E23271, E24296, F21376, F22361, F22362, F22382, F23369, F23370, G21490, G21504, G22385, G23384, H21506, H21512, H21530, H23450, H23451, I22479, I22481, I22495, I23466, I23498, I24511, I24523, J21680, J21691, K21777, K21801, K21806, K22597, K22609, K22632, K22663, K24650, K24679, L21812, L21823, L22674, L22711, L23649.
Distribution was worldwide, including the U.S. states of TX, MI, FL, IN, MO, CA, VA, NJ, PA, SC, TN, RI, and NY.
What You Should Do
Integra LifeSciences has notified customers through email, fax, letter, press release, telephone, and direct visits. Healthcare providers and consumers should immediately check their inventory for the affected lot numbers. If you possess any of the recalled products, follow the instructions provided in the firm's notification for returns or disposal.
Why This Matters
A breach in the sterile barrier of a medical dressing intended for wound care can lead to contamination, potentially increasing the risk of infection for patients.
Source
FDA (Recall Number: Z-1364-2026)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category